Glycogenesis (Glycogen Synthesis)
- Compartment
- Cytosol (glycogen particle)
- Main tissue
- Liver, skeletal muscle
- Rate-limiting
- Glycogen synthase
- Steps
- 6
Reaction steps
In source order, 6 total
-
1
Glucose + ATP → glucose-6-phosphate + ADP
› Notes
Hexokinase in muscle and most tissues or glucokinase in liver phosphorylates glucose using ATP and Mg2+. This irreversible trapping step channels glucose toward intracellular metabolism, including glycogen synthesis.
-
2
Glucose-6-phosphate ↔ glucose-1-phosphate
› Notes
Phosphoglucomutase reversibly transfers the phosphate through a glucose-1,6-bisphosphate intermediate; a catalytic phosphoserine is primed by glucose-1,6-bisphosphate. This reaction directs glucose carbon toward activated-sugar formation.
-
3
Glucose-1-phosphate + UTP → UDP-glucose + PPi
› Notes
UDP-glucose pyrophosphorylase requires UTP and Mg2+ to activate glucose as UDP-glucose. Subsequent hydrolysis of pyrophosphate by ubiquitous inorganic pyrophosphatase (PPi + H2O → 2 Pi) drives the overall activation forward; the activation sequence is effectively irreversible.
-
4
UDP-glucose + glycogenin–Tyr-OH → glycogenin–Tyr-O-glucose + UDP; repeated additions form a short alpha(1→4)-glucosyl primer
↪ glycogenin–Tyr-O-glucose + UDP; repeated additions form a short alpha(1 → 4)-glucosyl primer
› Notes
Glycogenin is an autoglycosylating protein that uses UDP-glucose and divalent cation (typically Mg2+). It creates the required primer, usually about 8 residues long, because glycogen synthase cannot initiate a new chain de novo.
-
5
UDP-glucose + glycogen(n) → glycogen(n+1) + UDP
› Notes
Glycogen synthase transfers glucose from UDP-glucose to a nonreducing end, forming an alpha(1→4) glycosidic bond. This is the principal rate-limiting and committed elongation step; it requires a pre-existing primer and is activated allosterically by glucose-6-phosphate.
-
6
An alpha(1→4)-linked chain segment → alpha(1→6)-branched glycogen
↪ 4)-linked chain segment → alpha(1 → 6)-branched glycogen
› Notes
The glycogen branching enzyme (amylo-alpha(1,4)→alpha(1,6)-transglycosylase; 4:6 transferase) transfers a terminal block of roughly 6–7 residues from a sufficiently long chain to the C6 hydroxyl of an internal glucose residue. It creates an alpha(1→6) branch at least several residues away from another branch, increasing solubility and the number of nonreducing ends for future synthesis and degradation.
Showing all 6 steps.
Regulation
What speeds each enzyme up and what slows it down
Glycogen synthase
Glucose-6-phosphate; dephosphorylation
Phosphorylation by protein kinase A, glycogen synthase kinase 3, and other kinases
Insulin activates protein phosphatase 1 and inhibits glycogen synthase kinase 3, promoting dephosphorylation/activation; glucagon in liver and epinephrine inhibit through cAMP/protein kinase A
Glycogenin
Availability of UDP-glucose
Lack of primer function
No major acute independent hormonal regulation
Glycogen branching enzyme
Adequate elongated alpha(1→4) chains
—
No dominant acute hormonal regulation; expression influences branching architecture
Overview
Glycogenesis stores excess glucose as glycogen, a highly branched alpha-glucan that provides a rapidly mobilizable, osmotically economical glucose reserve. Liver glycogen buffers blood glucose between meals, whereas skeletal-muscle glycogen supplies local fuel for contraction. Synthesis occurs when glucose and energy are abundant, particularly after a carbohydrate-containing meal.
Cellular location
Glycogen synthesis occurs in the cytosol on glycogen particles, which contain enzymes and regulatory proteins organized around a glycogenin core. It is most active in hepatocytes and skeletal myofibers; cardiac muscle, kidney, adipose tissue, glia, and other cells also contain smaller stores. The relevant glucose-6-phosphate and glucose-1-phosphate reactions take place in the cytosol.
Net energetics
For each glucosyl residue added from free glucose, phosphorylation costs 1 ATP, and UDP-glucose formation consumes 1 UTP (energetically equivalent to ATP because UTP is regenerated from UDP by nucleoside diphosphate kinase at ATP expense). Thus the cost is 2 ATP equivalents per residue stored from free glucose; no NADH, NADPH, FADH2, or GTP is formed. For glucose-6-phosphate entering directly, only the UTP-equivalent cost is required.
Clinical significance
Branching permits compact storage while allowing simultaneous access by many glycogen synthase or glycogen phosphorylase molecules at nonreducing ends. Insulin-stimulated glycogenesis in liver limits postprandial hyperglycemia, while muscle glycogenesis replenishes exercise-depleted local stores. Glycogen synthase deficiency causes glycogen storage disease (GSD) type 0, characterized by low hepatic glycogen, fasting ketotic hypoglycemia, and postprandial hyperglycemia; branching enzyme deficiency (GSD IV, Andersen disease) forms poorly branched polyglucosan and can cause progressive liver disease.
Recent literature
Live Europe PMC search
Europe PMC · fetched just now · sorted by publication date
-
1
Hepatocyte SLC31A1-dependent copper accumulation contributes to hepatic glucose and lipid metabolic disturbances through AMPKα1 inactivation.
Cheng YQ, Wei M, Yang L, Zhuang YY, Lu QB. · 2026-09-11
open access unreviewed -
2
Wubie Fanchun Formula-inducible metabolites in primary ovarian insufficiency model mice that facilitate ovarian renovation.
Chen Y, Chen S, Song B, Xia X, Zhang K, Chen L, Chi L, Wang Q. · 2026-05-12
open access unreviewed -
3
Spatiotemporal dynamics of the host-tumor metabolic interface: Implications for precision nutritional oncology.
Li M, Huang C, Yu S. · 2026-07-02
open access unreviewed -
4
Effects of Roasting on the Antioxidant and Lipid‐Modulating Activities of Argania spinosa Oil Under Diabetic Conditions
Daoudi N, Aziz M, Choukri M, Younous Y, Bouallegue A, Elossaily G, Gaafar A, Said M, Ali H, Bnouham M. · 2026-10-01
open access unreviewed -
5
<i>S</i>-Nitrosylation of glycogen phosphorylase regulates nuclear glycogenolysis and is impaired in metabolic liver disorders.
Soria LR, D'Alessio AM, Casertano V, Polishchuk E, Pasquadibisceglie A, Boffa I, Diana A, De Cegli R, De Stef… · 2026-10-02
open access unreviewed -
6
Renal glycogen handling in diabetes: A narrative review of diabetic kidney disease pathogenesis.
Ashok D, Manjrekar PA, Shetty BC, Sailet SS. · 2026-10-01
open access unreviewed -
7
Clinical trials in a dish: cardiometabolic drug development with biological and digital twins.
Patra D, Sayed IM, Venkateshappa R, Palaniappan L, McLaughlin T, Wu JC. · 2026-10-01
open access unreviewed -
8
A Migraine-Associated Na/K-ATPase Mutation Disrupts Hepatic Glucose Uptake and Peripheral Metabolism in Mice.
Pessoa MT, Sidarala V, Pierre SV. · 2026-10-01
unreviewed -
9
Impaired Hepatic Glucose Metabolism Is Associated With Glucose Intolerance in Mice Carrying α<sub>2</sub> Isoform Na,K-ATPase Mutation.
Staehr C, Nguyen TD, Pedersen TM, Vendelbo M, Beck HC, Kjolby M, Rajanathan R, Bouzinova EV, Jessen N, Jeppes… · 2026-10-01
cited 1× open access unreviewed -
10
Glucose metabolism in osteoporosis: A potential therapeutic target (Review).
Peng S, Yao Z, Guo J, Zhang C, Yang K, Tao L. · 2026-08-21
open access unreviewed
External claims. These come from an index outside this database and are not checked against it. Treat them as leads.